B. Braun Achieves FDA Clearance for Next-Gen AQUAbase® Reverse Osmosis System

B. Braun Introduces Revolutionary Dialysis Solution: AQUAbase nX – Purity without Chemicals

BETHLEHEM, Pa., Sept. 18, 2023 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a pioneer in smart infusion therapy and pain management, is proud to announce its latest innovation – the AQUAbase nX Reverse Osmosis System, receiving a resounding 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The AQUAbase nX isn’t just another dialysis system; it’s a game-changer. This single-stage reverse osmosis marvel delivers top-tier water quality for dialysis patients without relying on harsh chemicals. Its ingenious design boasts an astounding up to 75% raw water conversion rate, a breakthrough that not only conserves precious water resources but also slashes power, pre-treatment, and equipment maintenance costs.1

Jonathan Stapley, Senior Director of Marketing, Active Devices, couldn’t contain his enthusiasm: “We are thrilled to enhance our array of top-notch hemodialysis products with the AQUAbase nX. It’s a compact solution tailored for smaller facilities, complete with heat disinfection that significantly reduces the need for chemical additives.”

The system’s stainless steel piping is meticulously engineered to minimize dead space in the main ring, effectively thwarting any microbial contamination threats. With customizable capacity options ranging from 250 L/h to 750 L/h, the AQUAbase nX is a versatile and space-saving solution perfectly suited for hospitals, dialysis centers, or skilled nursing facilities, accommodating anywhere from five to 18 dialysis patients. The seven-inch touchscreen display offers direct access to pertinent settings and real-time status updates.

About B. Braun

At the forefront of innovation in smart infusion therapy and pharmacy products, B. Braun Medical Inc. (B. Braun) is not just a company; it’s a beacon of patient-centric excellence. With a relentless commitment to safety, sustainability, and elevating healthcare outcomes, B. Braun is your trusted partner in the quest for better patient care.

Our mission is crystal clear: empower healthcare providers to focus on what truly matters – their patients. We’re not just a company; we’re your ally in the journey towards better healthcare. Nestled in the heart of Bethlehem, Pennsylvania, B. Braun stands tall as a beacon of innovation.

Part of the illustrious B. Braun Group of Companies in the U.S., which encompasses B. Braun Interventional Systems, Aesculap®, and CAPS®, we’re a team of over 8,500 dedicated individuals, spanning more than 30 locations across North America. And our global family is even more extensive, with over 64,000 employees in 64 countries.

At B. Braun, we don’t just believe in excellence; we share it. Guided by our ‘Sharing Expertise®’ philosophy, we foster a vibrant exchange of knowledge with our customers, partners, and clinicians. Together, we tackle the most pressing challenges in healthcare, driving improvements in care quality and cost-effectiveness.

Leave a Comment